Aquatic Exercise Study for Breast Cancer Patients With Lymphedema
Lymphedema
About this trial
This is an interventional treatment trial for Lymphedema focused on measuring Lymphedema, Aquatic Exercise, Breast Cancer
Eligibility Criteria
Inclusion Criteria:
- Breast cancer patients with Lymphedema
- Patients must have received standard Lymphedema treatment (Complete Decongestive Therapy) prior to participating in the study.
- Patients undergoing treatment will require written permission from their physician
- Complete an assessment by a licensed physical therapist before beginning the exercise program
- Patients must sign a consent form to participate
Exclusion Criteria:
- Patients undergoing treatment without physician's written permission
- Patients with health problems that contraindicate exercise
- Patients are not eligible if the physical therapy assessment identifies a contraindication to participation
Inclusion of Women and Minorities:
- Men, women and minorities with breast cancer related lymphedema are eligible
Sites / Locations
- Baylor Sammons Breast Center
Arms of the Study
Arm 1
Arm 2
Active Comparator
No Intervention
Aquatic Exercise arm
Control - No Exercise Arm
Participants will attend 12 classes of aquatic exercise program (2-3 classes/weekly). Each one hour class is held in warm water pool which is 89 degrees and 3.5'-4'deep.Classes include low impact, dynamic movements for warm up, stretching and breathing exercises, upper and lower body resistance training, and cool down activities. Participants will be evaluated for Circumference & volumetric measurement of the affected limb, BMI, weight and height at the baseline, at 3rd week and at 6th week. Participant will complete a quality of life survey (QOL)at baseline, 6 week, 6 and 12 month.
No exercise will be performed in Control arm. Participants will be evaluated for Circumference & volumetric measurement of the affected limb, BMI, weight and height at the baseline, at 3rd week and at 6th week. Participant will complete a quality of life survey (QOL) at baseline, 6 week, 6 and 12 month.